• Richard Kadri-Langford

Occuity wins Chinese innovation award


Occuity is pleased to announce that we have been awarded a “Foreigner Project of the Competition” prize at the 2020 Hangzhou Innovation and Entrepreneurship Competition.

The competition, which has been running annually since 2015, looks to identify and attract global high-tech innovative talent and entrepreneurial projects which resonate with the entrepreneurial spirit of the city of Hangzhou. Occuity was invited to present at the competition by Zemu Venture Capital [1] and 500 Startups [2]. Joining more than three hundred international innovators in the early rounds of the event, following a series of online presentations we were delighted to be selected as a finalist in our category before receiving our award.


At each stage of the competition our presentation was well received; generating in depth technical and commercial discussions. Some one hundred and twenty million people in China are estimated to be suffering from diabetes with a further one third of the population having pre-diabetes conditions.


Our products use patented optical technologies to identify changes in the eye which can be used for the early detection and monitoring of a number of chronic diseases. This fitted well with China’s desire to improve the quality of healthcare for its citizens through the adoption of innovative world-leading solutions. The offering from the Occuity team was particularly welcomed as it aims to provide a cost-effective route to early identification and monitoring of diabetes.


Commenting on the award, Occuity CEO Dr Dan Daly said, “We are delighted to receive the prize in the “Foreigner Project of the Competition” category. China is an outstanding market for our products, particularly in the diabetes space.” He added: “Occuity has global plans and this validation from one of the world’s largest diabetes markets shows how a UK company can address a problem that affects the whole world.”


[1] http://www.zemuvc.co/

[2] https://500.co/






142 views0 comments

Recent Posts

See All